組織学・細胞学の市場：検査タイプ、製品タイプ、検査タイプ、エンドユーザー別-2025-2030年の世界予測

組織学・細胞学市場は、2023年に208億6,000万米ドルと評価され、2024年には238億1,000万米ドルに達すると予測され、CAGR 14.25％で成長し、2030年には530億1,000万米ドルに達すると予測されています。

組織学と細胞学は、疾患プロセス、構造、機能性を研究するための細胞や組織サンプルの顕微鏡検査に焦点を当てた生命科学の重要な分野です。この分野の必要性は、疾患、特にがん、感染症、自己免疫疾患の診断における重要な役割にあります。用途は、診断目的の臨床現場、疾病メカニズム解明のための研究機関、薬剤開発のための製薬会社など多岐にわたる。最終用途の範囲は、病院、診療所、学術研究機関、バイオテクノロジー企業で構成され、ヘルスケアと生物医学研究における広大な有用性を強調しています。市場成長は、がんやその他の慢性疾患の世界の有病率の上昇に大きく影響され、組織学的および細胞学的アッセイにおける診断精度と精度の需要を牽引しています。さらに、サンプル調製の自動化、デジタル病理学、AIを活用した画像解析などの技術進歩は、より迅速で正確な診断を促進し、潜在的な成長機会を提供します。しかし、先進的な機器に伴う高コスト、厳しい規制要件、熟練した専門家の不足といった課題に直面しており、これが市場の成長をある程度制限しています。医療インフラが拡大し、個別化医療が浸透しつつある新興市場にはビジネスチャンスが豊富にあります。企業は、ワークフローを合理化し、診断能力を向上させる費用対効果の高いイノベーションとテクノロジーに投資することで、これらを活用することができます。技術革新の主な分野としては、ポイントオブケア検査用のポータブル機器の開発、アッセイの感度と特異性の向上、大規模分析のための堅牢なデータ管理システムの確立などが挙げられます。市場はダイナミックで、研究能力の向上と製品ポートフォリオの拡大を目的とした統合や提携が特徴です。企業が成功を収めるためには、共同研究開発、手頃な価格のソリューションによる高コストの障壁への対応、競争力を得るための規制基準へのコンプライアンスの確保に注力すべきです。

市場力学：急速に進化する組織学・細胞学市場の主要市場インサイトを公開

組織学・細胞学市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患診断における採用の増加
  • 病理検査室の標準化の進展
  • がん検診と臨床検査に対する有利な償還制度
• 市場抑制要因
  • 検査費用の高騰に伴う製品認知度の低下
• 市場機会
  • 細胞レベルの観察に特化した検査の継続的な採用
  • 複数の疾患の診断への応用を拡大するための業界各社の絶え間ない研究開発活動
• 市場の課題
  • 適切な診断には大量のサンプルが必要

ポーターの5つの力：組織学・細胞学市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：組織学・細胞学市場における外部からの影響の把握

外部マクロ環境要因は、組織学・細胞学市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析組織学・細胞学市場における競合情勢の把握

組織学・細胞学市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス組織学・細胞学市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、組織学・細胞学市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨組織学・細胞学市場における成功への道筋を描く

組織学・細胞学市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患診断における導入の増加
    • 病理学検査室の標準化の進展
    • がん検診と臨床検査に対する有利な償還制度
  • 抑制要因
    • 製品に対する認知度の低下とテストのコストの高騰
  • 機会
    • 細胞レベルの観察のための専門検査の継続的な導入
    • 業界関係者の間では、さまざまな病気の診断への応用を増やすために、継続的な研究開発活動が行われています。
  • 課題
    • 適切な診断には大量のサンプルが必要
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 組織学・細胞学の市場検査の種類別

• 細胞学
  • 乳がん
  • 子宮頸がん
• 組織学

第7章 組織学・細胞学の市場：製品別

• 消耗品と試薬
• 機器および分析ソフトウェアシステム

第8章 組織学・細胞学の市場テストタイプ別

• フローサイトメトリー
• 顕微鏡検査
• 分子遺伝学

第9章 組織学・細胞学の市場：エンドユーザー別

• 臨床診断
• クリニック
• 病院
• ライフサイエンス調査機関

第10章 南北アメリカの組織学・細胞学の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の組織学・細胞学の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの組織学・細胞学の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson & Company
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Hologic, Inc.
• Koninklijke Philips N.V.
• Medimeas Instruments
• Merck KGaA
• PerkinElmer Inc.
• Polysciences, Inc.
• StatLab Medical Products
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
• Trivitron Healthcare

LIST OF FIGURES

• FIGURE 1. HISTOLOGY & CYTOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. HISTOLOGY & CYTOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. HISTOLOGY & CYTOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. HISTOLOGY & CYTOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HISTOLOGY & CYTOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HISTOLOGY & CYTOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY HISTOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CONSUMABLE & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY INSTRUMENTS & ANALYSIS SOFTWARE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY MOLECULAR GENETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY LIFE SCIENCES RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 69. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 160. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 180. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 185. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. HISTOLOGY & CYTOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. HISTOLOGY & CYTOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The Histology & Cytology Market was valued at USD 20.86 billion in 2023, expected to reach USD 23.81 billion in 2024, and is projected to grow at a CAGR of 14.25%, to USD 53.01 billion by 2030.

Histology and cytology are essential branches of life sciences focused on the microscopic examination of cells and tissue samples to study disease processes, structure, and functionality. The necessity of this domain lies in its critical role in diagnosing diseases, particularly cancer, infectious diseases, and autoimmune disorders. Applications span across clinical settings for diagnostic purposes, research institutes for understanding disease mechanisms, and pharmaceutical companies for drug development. The end-use scope comprises hospitals, clinics, academic and research institutions, and biotechnology firms, highlighting the vast utility in healthcare and biomedical research. Market growth is significantly influenced by the rising prevalence of cancer and other chronic diseases globally, which drives the demand for diagnostic accuracy and precision in histological and cytological assays. Moreover, technological advancements such as automation in sample preparation, digital pathology, and AI-powered image analysis offer potential growth opportunities, facilitating faster and more accurate diagnostics. However, the market faces challenges such as high costs associated with advanced instruments, strict regulatory requirements, and a shortage of skilled professionals, which restrict growth to an extent. Opportunities abound in emerging markets where healthcare infrastructure is expanding, and personalized medicine is gaining traction. Businesses can capitalize on these by investing in cost-effective innovations and technologies that streamline workflow and improve diagnostic capabilities. Key areas for innovation include the development of portable devices for point-of-care testing, enhancing the sensitivity and specificity of assays, and establishing robust data management systems for large-scale analysis. The market is dynamic, characterized by consolidation and partnerships aimed at advancing research capabilities and expanding product portfolios. To thrive, companies should focus on collaborative research and development, addressing the high cost barrier through affordable solutions, and ensuring compliance with regulatory standards to gain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Histology & Cytology Market

The Histology & Cytology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing adoption in chronic disease diagnostics
  • Growing standardization of pathological laboratories
  • Favorable reimbursement schemes for cancer screening and laboratory testing
• Market Restraints
  • Reduced awareness of the product coupled with high cost of tests
• Market Opportunities
  • Ongoing adoption of specialized tests for cellular level observations
  • Constant research and development activities among industry players to increase its application in diagnosis of several diseases
• Market Challenges
  • Need for large amount of sample for appropriate diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Histology & Cytology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Histology & Cytology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Histology & Cytology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Histology & Cytology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Histology & Cytology Market

A detailed market share analysis in the Histology & Cytology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Histology & Cytology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Histology & Cytology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Histology & Cytology Market

A strategic analysis of the Histology & Cytology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Histology & Cytology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson & Company, Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Koninklijke Philips N.V., Medimeas Instruments, Merck KGaA, PerkinElmer Inc., Polysciences, Inc., StatLab Medical Products, Sysmex Corporation, Thermo Fisher Scientific, Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Histology & Cytology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type of Examination, market is studied across Cytology and Histology. The Cytology is further studied across Breast Cancer and Cervical Cancer.
• Based on Product, market is studied across Consumable & Reagents and Instruments & Analysis Software System.
• Based on Test Type, market is studied across Flow Cytometry, Microscopy, and Molecular Genetic.
• Based on End-user, market is studied across Clinical Diagnostics, Clinics, Hospitals, and Life Sciences Research Institutions.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing adoption in chronic disease diagnostics
    • 5.1.1.2. Growing standardization of pathological laboratories
    • 5.1.1.3. Favorable reimbursement schemes for cancer screening and laboratory testing
  • 5.1.2. Restraints
    • 5.1.2.1. Reduced awareness of the product coupled with high cost of tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing adoption of specialized tests for cellular level observations
    • 5.1.3.2. Constant research and development activities among industry players to increase its application in diagnosis of several diseases
  • 5.1.4. Challenges
    • 5.1.4.1. Need for large amount of sample for appropriate diagnosis
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Histology & Cytology Market, by Type of Examination

• 6.1. Introduction
• 6.2. Cytology
  • 6.2.1. Breast Cancer
  • 6.2.2. Cervical Cancer
• 6.3. Histology

7. Histology & Cytology Market, by Product

• 7.1. Introduction
• 7.2. Consumable & Reagents
• 7.3. Instruments & Analysis Software System

8. Histology & Cytology Market, by Test Type

• 8.1. Introduction
• 8.2. Flow Cytometry
• 8.3. Microscopy
• 8.4. Molecular Genetic

9. Histology & Cytology Market, by End-user

• 9.1. Introduction
• 9.2. Clinical Diagnostics
• 9.3. Clinics
• 9.4. Hospitals
• 9.5. Life Sciences Research Institutions

10. Americas Histology & Cytology Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Histology & Cytology Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Histology & Cytology Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Becton, Dickinson & Company
• 4. Danaher Corporation
• 5. F. Hoffmann-La Roche Ltd.
• 6. Hologic, Inc.
• 7. Koninklijke Philips N.V.
• 8. Medimeas Instruments
• 9. Merck KGaA
• 10. PerkinElmer Inc.
• 11. Polysciences, Inc.
• 12. StatLab Medical Products
• 13. Sysmex Corporation
• 14. Thermo Fisher Scientific, Inc.
• 15. Trivitron Healthcare